Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

PAVmed Q2 Adj. EPS $(0.05) Beats $(0.13) Estimate, Sales $6.000K Miss $10.000K Estimate

Author: Benzinga Newsdesk | August 14, 2025 07:01am
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.13) by 61.54 percent. This is a 94.05 percent increase over losses of $(0.84) per share from the same period last year. The company reported quarterly sales of $6.000 thousand which missed the analyst consensus estimate of $10.000 thousand by 40.00 percent. This is a 99.39 percent decrease over sales of $979.000 thousand the same period last year.

Posted In: PAVM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist